Cleared Traditional

K103266 - ISTAND

K103266 is an FDA 510(k) clearance for ISTAND, manufactured by Optovue, Inc.. The device is a Class 2 Ophthalmic device with product code HLI cleared through the Traditional 510(k) pathway after a 211-day FDA review.

K103266 · Optovue, Inc. · Ophthalmic device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jun 2011
Decision
211d
Days
Class 2
Risk

K103266 is an FDA 510(k) clearance for the ISTAND. Classified as Ophthalmoscope, Ac-powered (product code HLI), Class II - Special Controls.

Submitted by Optovue, Inc. (Fremont, US). The FDA issued a Cleared decision on June 3, 2011 after a review of 211 days - an extended review cycle.

This device falls under the Ophthalmic FDA review panel, regulated under 21 CFR 886.1570 - the FDA ophthalmic device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Ophthalmic review framework, consistent with the majority of Class II 510(k) submissions.

View all Optovue, Inc. devices

FDA 510(k) Submission Details - K103266

510(k) Number K103266 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received November 04, 2010
Decision Date June 03, 2011
Days to Decision 211 days
Submission Type Traditional
Review Panel Ophthalmic (OP)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
101d slower than avg
Panel avg: 110d · This submission: 211d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

HLI Device Classification - Class 2, Special Controls

Product Code HLI Ophthalmoscope, Ac-powered
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 886.1570
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Ophthalmic devices follow this clearance model.

Regulatory Peers - HLI Ophthalmoscope, Ac-powered

All 73
Devices cleared under the same product code (HLI) and FDA review panel - the closest regulatory comparables to K103266.
ENVISU SPECTRAL DOMAIN OPHTHALMIC IMAGING SYSTEM (SDOIS)
K120057 · Bioptigen, Inc. · May 2012
RTVUE XR OCT
K120238 · Optovue, Inc. · Apr 2012
RHA2020
K111531 · Annidis Health Systems Corp. · Jul 2011
AAIO-7, AAIO WIRLESS
K110205 · Appasamy Associates · Feb 2011
RTVUE MODEL RTVUE 100
K101505 · Optovue, Inc. · Sep 2010
R T VUE WITH SOFTWARE 5.0 MODEL: R I VUE 100
K100861 · Optovue, Inc. · Jun 2010